BiondVax Pharmaceuticals (NASDAQ:BVXV) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a report issued on Saturday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance BVXV stock opened at $2.02 on Friday. The company has a market cap of $3.78 million, a P/E ratio of -0.50 and a […]

Related Keywords

,Hedge Funds Weigh In On Biondvax Pharmaceuticals ,Biondvax Pharmaceuticals ,Envestnet Asset Management Inc ,Nasdaq ,Biondvax Pharmaceuticals Ltd ,News Ratings For Biondvax Pharmaceuticals Daily ,Biondvax Pharmaceuticals Stock Performance ,Get Rating ,Vax Pharmaceuticals ,Asset Management ,Biondvax Pharmaceuticals Daily ,Nasdaq Bvxv ,Bvxv ,Medical ,Initiated Coverage ,Stocknews Com ,